{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:49:14Z","timestamp":1790729354241,"version":"4.1.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5,15]]},"DOI":"10.1093\/cid\/civ096","type":"journal-article","created":{"date-parts":[[2015,2,11]],"date-time":"2015-02-11T05:39:56Z","timestamp":1423633196000},"page":"1472-1480","source":"Crossref","is-referenced-by-count":50,"title":["Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against Invasive Disease and Hospital-Treated Pneumonia Among People Aged \u226565 Years: A Retrospective Case-Control Study"],"prefix":"10.1093","volume":"60","author":[{"given":"Maya","family":"Leventer-Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becca S.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Brufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra J.","family":"Cohen-Stavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Hoshen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran D.","family":"Balicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,2,10]]},"reference":[{"issue":"Suppl 1","key":"key\n\t\t\t\t20170510132817_CIV096C1","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0264-410X(99)00122-X","article-title":"The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known","volume":"17","author":"Fedson","year":"1999","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170510132817_CIV096C2","first-page":"2392","volume-title":"Bennett's principles and practice of infectious diseases","author":"Musher","year":"2005","edition":"6th ed"},{"key":"key\n\t\t\t\t20170510132817_CIV096C3","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.4161\/hv.27947","article-title":"Estimating the burden of hospitalization for pneumococcal pneumonia in a general population aged 50 years or older and implications for vaccination strategies","volume":"10","author":"Amodio","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20170510132817_CIV096C4","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1086\/507340","article-title":"Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study","volume":"43","author":"Vila-Corcoles","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"Suppl 5","key":"key\n\t\t\t\t20170510132817_CIV096C5","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1111\/j.1469-0691.2012.03937.x","article-title":"Understanding the burden of pneumococcal disease in adults","volume":"18","author":"Blasi","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170510132817_CIV096C6","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1001\/jama.294.21.2712","article-title":"Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988\u20132002","volume":"294","author":"Fry","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170510132817_CIV096C7","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.285.13.1729","article-title":"Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995\u20131998: opportunities for prevention in the conjugate vaccine era","volume":"285","author":"Robinson","year":"2001","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170510132817_CIV096C8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000070405","article-title":"Impact of pneumococcal vaccination on morbidity and mortality of geriatric patients: a case-controlled study","volume":"49","author":"Wagner","year":"2003","journal-title":"Gerontology"},{"issue":"RR-11","key":"key\n\t\t\t\t20170510132817_CIV096C9","first-page":"1","article-title":". Prevention of pneumococcal disease among infants and children\u2014use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine\u2014recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Nuorti","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20170510132817_CIV096C10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1517\/14712598.2012.636348","article-title":"The development of 13-valent pneumococcal conjugate vaccine and its possible use in adults","volume":"12","author":"Frenck","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"key\n\t\t\t\t20170510132817_CIV096C11","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/j.vaccine.2007.06.004","article-title":"Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults","volume":"25","author":"Scott","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170510132817_CIV096C12","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.4161\/hv.28962","article-title":"Pneumococcal conjugate vaccines for adults: reasons for optimism and for caution","volume":"10","author":"Weinberger","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20170510132817_CIV096C13","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the advisory committee on immunization practices (ACIP)","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20170510132817_CIV096C14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/0003-4819-101-3-325","article-title":"A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections","volume":"101","author":"Shapiro","year":"1984","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170510132817_CIV096C15","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"325","author":"Shapiro","year":"1991","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170510132817_CIV096C16","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1001\/archinte.1994.00420230051007","article-title":"Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials","volume":"154","author":"Fine","year":"1994","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170510132817_CIV096C17","first-page":"2381","article-title":"Clinical effectiveness of pneumococcal vaccine. Meta-analysis","volume":"45","author":"Hutchison","year":"1999","journal-title":"Can Fam Physician"},{"key":"key\n\t\t\t\t20170510132817_CIV096C18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/B:EJEP.0000024701.94769.98","article-title":"The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses","volume":"19","author":"Melegaro","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"key\n\t\t\t\t20170510132817_CIV096C19","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1016\/S0264-410X(01)00217-1","article-title":"Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials","volume":"19","author":"Cornu","year":"2001","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170510132817_CIV096C20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2296-1-1","article-title":"Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials","volume":"1","author":"Moore","year":"2000","journal-title":"BMC Family Pract"},{"key":"key\n\t\t\t\t20170510132817_CIV096C21","first-page":"CD000422","article-title":"Vaccines for preventing pneumococcal infection in adults","volume":"1","author":"Moberley","year":"2013","journal-title":"Cochrane Database Syst Reviews"},{"key":"key\n\t\t\t\t20170510132817_CIV096C22","first-page":"101","article-title":"23-valent pneumococcal polysaccharide vaccine (PPV23) for the prevention of invasive pneumococcal diseases (IPDs) in the elderly: is it really effective?","volume":"53","author":"Cadeddu","year":"2012","journal-title":"J Prev Med Hyg"},{"key":"key\n\t\t\t\t20170510132817_CIV096C23","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/S0264-410X(02)00112-3","article-title":"Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults","volume":"20","author":"Watson","year":"2002","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170510132817_CIV096C24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1503\/cmaj.080734","article-title":"Efficacy of pneumococcal vaccination in adults: a meta-analysis","volume":"180","author":"Huss","year":"2009","journal-title":"CMAJ"},{"key":"key\n\t\t\t\t20170510132817_CIV096C25","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.vaccine.2003.09.027","article-title":"Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults","volume":"22","author":"Fedson","year":"2004","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170510132817_CIV096C26","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.vaccine.2014.02.048","article-title":"The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study","volume":"32","author":"Wiemken","year":"2014","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170510132817_CIV096C27","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJMoa022678","article-title":"Effectiveness of pneumococcal polysaccharide vaccine in older adults","volume":"348","author":"Jackson","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170510132817_CIV096C28","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1016\/j.vaccine.2010.08.010","article-title":"Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan","volume":"28","author":"Kawakami","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170510132817_CIV096C29","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/cid\/ciu002","article-title":"Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged >\/=60 years: 3 years of follow-up in the CAPAMIS study","volume":"58","author":"Ochoa-Gondar","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170510132817_CIV096C30","first-page":"822","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged >\/=65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63","author":"Tomczyk","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20170510132817_CIV096C31","first-page":"578","article-title":"The effect of the introduction of pneumococcal vaccination for adults as a quality measure on vaccination rates in Clalit Health Services [in Hebrew]","volume":"150","author":"Cohen","year":"2011","journal-title":"Harefuah"},{"key":"key\n\t\t\t\t20170510132817_CIV096C32","article-title":"Technical reference guide: version 9.0","author":"The Johns Hopkins Adjusted Clinical Groups System","year":"2009"},{"key":"key\n\t\t\t\t20170510132817_CIV096C33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/thx.2009.129502","article-title":"Clinical and economic burden of community-acquired pneumonia among adults in Europe","volume":"67","author":"Welte","year":"2012","journal-title":"Thorax"},{"key":"key\n\t\t\t\t20170510132817_CIV096C34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.rmed.2008.08.006","article-title":"Epidemiology of community-acquired pneumonia in older adults: a population-based study","volume":"103","author":"Vila-Corcoles","year":"2009","journal-title":"Respir Med"},{"key":"key\n\t\t\t\t20170510132817_CIV096C35","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1086\/429236","article-title":"Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case-control study","volume":"40","author":"Dominguez","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170510132817_CIV096C36","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1016\/j.vaccine.2012.03.007","article-title":"A possible relationship of natural killer T cells with humoral immune response to 23-valent pneumococcal polysaccharide vaccine in clinical settings","volume":"30","author":"Miyasaka","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170510132817_CIV096C37","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1586\/14760584.5.5.651","article-title":"Nasopharyngeal colonization: a target for pneumococcal vaccination","volume":"5","author":"Kayhty","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20170510132817_CIV096C38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2334-10-73","article-title":"Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older","volume":"10","author":"Vila-Corcoles","year":"2010","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20170510132817_CIV096C39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1128\/CMR.16.2.308-318.2003","article-title":"Pneumococcal vaccination and revaccination of older adults","volume":"16","author":"Artz","year":"2003","journal-title":"Clin Microbiol Rev"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/60\/10\/1472\/16787388\/civ096.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T18:43:42Z","timestamp":1503427422000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/civ096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,10]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,2,10]]},"published-print":{"date-parts":[[2015,5,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/civ096","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2,10]]}}}